Naloxone Hydrochloride Inhalant
Product Images NDC 50090-5908

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 50090-5908). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905908)

Naloxone Hydrochloride Nasal Spray 4 mg/0.1 mL label from A-S Medication Solutions. The label indicates each spray contains 4 mg naloxone HCl, with 0.1 mL per spray. The package includes two 0.1 mL intranasal sprays in a two-pack. The product NDC is 50090-5908 and storage instructions specify room temperature, not exceeding 77 degrees Fahrenheit.*

FDA Label Image

Chemical Structure (Narcan 01)

Chemical structure of Naloxone Hydrochloride. The diagram shows the molecular framework including rings, hydroxyl groups, and other functional groups consistent with Naloxone Hydrochloride's structure.*

FDA Label Image

Figure 1(a) (Narcan 02)

A line graph depicting Naloxone plasma concentration over six hours postdose for various nasal spray doses and injection. The x-axis shows hours postdose, and the y-axis shows plasma concentration in mg/mL. Multiple lines compare different naloxone dosages and delivery methods, including 2 mg and 4 mg sprays in one or both nostrils and a 0.4 mg intramuscular injection.*

FDA Label Image

Figure 1(b) (Narcan 03)

A line graph depicting naloxone plasma concentration (ng/mL) over hours postdose for different dosages and administration routes, including 2 mg and 4 mg nasal sprays in various concentrations and an 0.4 mg intramuscular injection. The graph shows plasma concentration trends over a one-hour period with error bars indicating variability.*

FDA Label Image

Figure (Narcan 04)

An instructional illustration showing a person peeling back a foil or paper strip from a small packet labeled as Naloxone nasal spray. The image demonstrates how to open the individual unit-dose nasal inhalant packaging for Naloxone Hydrochloride Nasal 4 mg/.1mL by A-S Medication Solutions.*

FDA Label Image

Figure (Narcan 05)

An instructional illustration showing a hand holding a nasal inhalant device with labeled parts: 'NOZZLE' and 'PLUNGER.' This diagram is related to the administration of Naloxone Hydrochloride Nasal inhalant.*

FDA Label Image

Figure (Narcan 06)

An instructional illustration showing a hand administering a nasal inhalant spray to a person's nose. The person is tilted slightly backward to facilitate inhalation into the nasal passage.*

FDA Label Image

Figure (Narcan 07)

An instructional illustration showing how to administer a nasal inhalant spray. The image depicts a hand holding a nasal spray device positioned near a person's nostril, demonstrating the correct usage method for nasal delivery.*

FDA Label Image

Figure (Narcan 08)

An instructional illustration showing a person positioned on their side with one hand supporting the head and the knee preventing the body from rolling onto the stomach. This diagram likely demonstrates a recovery or safety position associated with the use of Naloxone Hydrochloride Nasal inhalant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.